{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:05:16Z","timestamp":1778547916326,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1-3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1163\/156856005774423917","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T22:33:54Z","timestamp":1128724434000},"page":"281-289","source":"Crossref","is-referenced-by-count":9,"title":["Histamine regulates growth of malignant melanoma implants via H2 receptors in mice"],"prefix":"10.1007","volume":"13","author":[{"given":"Kazuyoshi","family":"Tomita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"77442391_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00008390-200306000-00003","volume":"13","author":"Z. Darvas","year":"2003","unstructured":"Darvas, Z., Sakurai, E., Schwelberger, H. G., et al. (2003). Autonomous histamine metabolism in human melanoma cells, Melanoma Res. 13, 239\u2013246.","journal-title":"Melanoma Res."},{"key":"77442391_CR2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00262-004-0525-9","volume":"53","author":"F. Donskov","year":"2004","unstructured":"Donskov, F., Bennedsgaard, K. M., Hokland, M., et al. (2004). Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma, Cancer Immunol. Immunother. 53, 729\u2013739.","journal-title":"Cancer Immunol. Immunother."},{"key":"77442391_CR3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1471-4906(01)02050-6","volume":"22","author":"A. Falus","year":"2001","unstructured":"Falus, A., Hegyesi, H., Lazar-Molnar, E., et al. (2001). Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation, Trends Immunol. 22, 648\u2013652.","journal-title":"Trends Immunol."},{"key":"77442391_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1523-1747.2000.00054.x","volume":"115","author":"M. Haak-Frendscho","year":"2000","unstructured":"Haak-Frendscho, M., Darvas, Z., Hegyesi, H., et al. (2000). Histidine decarboxylase expression in human melanoma, J. Invest. Dermatol. 115, 345\u2013352.","journal-title":"J. Invest. Dermatol."},{"key":"77442391_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.0022-202x.2001.01406.x","volume":"117","author":"H. Hegyesi","year":"2001","unstructured":"Hegyesi, H., Somlai, B., Varga, V. L., et al. (2001). Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides, J. Invest. Dermatol. 117, 151\u2013153.","journal-title":"J. Invest. Dermatol."},{"key":"77442391_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/sonc.2002.33081","volume":"29","author":"K. Hellstrand","year":"2002","unstructured":"Hellstrand, K. (2002). Histamine in cancer immunotherapy: a preclinical background, Semin. Oncol. 29, 35\u201340.","journal-title":"Semin. Oncol."},{"key":"77442391_CR7","first-page":"3698","volume":"35","author":"P. Janik","year":"1975","unstructured":"Janik, P., Briand, P. and Hartmann, N. R. (1975). The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors, Cancer Res. 35, 3698\u20133704.","journal-title":"Cancer Res."},{"key":"77442391_CR8","first-page":"537","volume":"23","author":"A. S. Jorkov","year":"2003","unstructured":"Jorkov, A. S., Donskov, F., Steiniche, T., et al. (2003). Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride, Anticancer Res. 23, 537\u2013542.","journal-title":"Anticancer Res."},{"key":"77442391_CR9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/eji.1830260620","volume":"26","author":"K. Kono","year":"1996","unstructured":"Kono, K., Salazar-Onfray, F., Petersson, M., et al. (1996). Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity, Eur. J. Immunol. 26, 1308\u20131313.","journal-title":"Eur. J. Immunol."},{"key":"77442391_CR10","first-page":"1837","volume":"24","author":"P. Lindner","year":"2004","unstructured":"Lindner, P., Rizell, M., Mattsson, J., et al. (2004). Combined treatment with histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma, Anticancer Res. 24, 1837\u20131842.","journal-title":"Anticancer Res."},{"issue":"Suppl.2","key":"77442391_CR11","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1007\/s000110050731","volume":"50","author":"E. L. Molnar","year":"2001","unstructured":"Molnar, E. L., Cricco, G., Martin, G., et al. (2001). Histamine as a potential autocrine regulator of melanoma, Inflamm. Res. 50(Suppl. 2), S102\u2013S103.","journal-title":"Inflamm. Res."},{"key":"77442391_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00008390-199604000-00003","volume":"6","author":"J. L. Reynolds","year":"1996","unstructured":"Reynolds, J. L., Akhter, J. and Morris, D. L. (1996). In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines, Melanoma Res. 6, 95\u201399.","journal-title":"Melanoma Res."},{"key":"77442391_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1254\/jphs.93.321","volume":"93","author":"K. Tomita","year":"2003","unstructured":"Tomita, K., Izumi, K. and Okabe, S. (2003). Roxatidine-and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice, J. Pharmacol. Sci. 93, 321\u2013330.","journal-title":"J. Pharmacol. Sci."},{"key":"77442391_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1254\/jphs.FP0040691","volume":"97","author":"K. Tomita","year":"2005","unstructured":"Tomita, K. and Okabe, S. (2005). Exogenous histamine stimulates colorectal cancer implant growth via immunosuppression in mice, J. Pharmacol. Sci. 97, 116\u2013123.","journal-title":"J. Pharmacol. Sci."}],"container-title":["InflammoPharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1163\/156856005774423917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:42:18Z","timestamp":1572896538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1163\/156856005774423917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":14,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["77442391"],"URL":"https:\/\/doi.org\/10.1163\/156856005774423917","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}